Macrophages in MS have been shown to obtain an intermediate phenotype with high expression of CD68, CD86, and CD163 (45), skewing macrophages locally toward a protective M2 phenotype has been shown to promote remyelination (22). This evidence concerns the gene CD68 and myeloid sarcoma.